Cargando…

Targeting Nrf2 may reverse the drug resistance in ovarian cancer

BACKGROUND: Acquired resistance to therapeutic drugs has become an important issue in treating ovarian cancer. Studies have shown that the prevalent chemotherapy resistance (cisplatin, paclitaxel etc.) for ovarian cancer occurs partly because of decreased production of reactive oxygen species within...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Danjie, Hong, Xiaoling, Zhao, Feijie, Ci, Xinxin, Zhang, Songling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890806/ https://www.ncbi.nlm.nih.gov/pubmed/33596893 http://dx.doi.org/10.1186/s12935-021-01822-1

Ejemplares similares

UBE2E2 enhances Snail-mediated epithelial-mesenchymal transition and Nrf2-mediated antioxidant activity in ovarian cancer
por: Hong, Xiaoling, et al.
Publicado: (2023)

Food-Derived Pharmacological Modulators of the Nrf2/ARE Pathway: Their Role in the Treatment of Diseases
por: Zhao, Feijie, et al.
Publicado: (2021)

Nrf2 Signaling Pathway Mediates the Protective Effects of Daphnetin Against D-Galactose Induced-Premature Ovarian Failure
por: Zhang, Mengwen, et al.
Publicado: (2022)

The promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer
por: Zhang, Mengwen, et al.
Publicado: (2023)

Role of Nrf2 and Its Activators in Respiratory Diseases
por: Liu, Qinmei, et al.
Publicado: (2019)

Reversing platinum resistance in ovarian cancer multicellular spheroids by targeting Bcl-2
por: Yang, Ya’nan, et al.
Publicado: (2019)

Low expression of KCNN3 may affect drug resistance in ovarian cancer
por: Liu, Xia, et al.
Publicado: (2018)

Role of NRF2 in Ovarian Cancer
por: Tossetta, Giovanni, et al.
Publicado: (2022)

Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways
por: Yang, Huahong, et al.
Publicado: (2019)

Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study
por: Wang, Rui, et al.
Publicado: (2022)

Farrerol Ameliorates APAP-induced Hepatotoxicity via Activation of Nrf2 and Autophagy
por: Wang, Lidong, et al.
Publicado: (2019)

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer
por: Bai, Yang, et al.
Publicado: (2016)

Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer
por: Zhao, Meng-Dan, et al.
Publicado: (2019)

Purvalanol A induces apoptosis and reverses cisplatin resistance in ovarian cancer
por: Zhang, Xiaoyi, et al.
Publicado: (2022)

Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
por: Roh, Jong-Lyel, et al.
Publicado: (2016)

Reversal of Radiotherapy Resistance of Ovarian Cancer Cell Strain CAOV3/R by Targeting lncRNA CRNDE
por: Yang, Wencui, et al.
Publicado: (2021)

Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
por: Alatise, Kharimat Lora, et al.
Publicado: (2022)

Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
por: McFadden, Melayshia, et al.
Publicado: (2021)

Tissue transglutaminase: a new target to reverse cancer drug resistance
por: Budillon, Alfredo, et al.
Publicado: (2011)

Diosmetin Alleviates Lipopolysaccharide-Induced Acute Lung Injury through Activating the Nrf2 Pathway and Inhibiting the NLRP3 Inflammasome
por: Liu, Qinmei, et al.
Publicado: (2018)

Licochalcone A Upregulates Nrf2 Antioxidant Pathway and Thereby Alleviates Acetaminophen-Induced Hepatotoxicity
por: Lv, Hongming, et al.
Publicado: (2018)

ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells
por: Xu, Yunjie, et al.
Publicado: (2018)

Quinacrine-Mediated Inhibition of Nrf2 Reverses Hypoxia-Induced 5-Fluorouracil Resistance in Colorectal Cancer
por: Kim, Ha Gyeong, et al.
Publicado: (2019)

Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
por: Zhou, Hai-Hong, et al.
Publicado: (2019)

PM2.5 increases susceptibility to acute exacerbation of COPD via NOX4/Nrf2 redox imbalance-mediated mitophagy
por: Fan, Xiaoye, et al.
Publicado: (2022)

Farrerol Ameliorated Cisplatin-Induced Chronic Kidney Disease Through Mitophagy Induction via Nrf2/PINK1 Pathway
por: Ma, Ning, et al.
Publicado: (2021)

HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer
por: Lombardi, Rita, et al.
Publicado: (2021)

HSP90AB1 as the Druggable Target of Maggot Extract Reverses Cisplatin Resistance in Ovarian Cancer
por: Wang, Daojuan, et al.
Publicado: (2023)

Quercetin reverses 5-fluorouracil resistance in colon cancer cells by modulating the NRF2/HO-1 pathway
por: Tang, Zhongzhu, et al.
Publicado: (2023)

The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer
por: McFadden, Melayshia, et al.
Publicado: (2023)

Isoorientin Ameliorates APAP-Induced Hepatotoxicity via Activation Nrf2 Antioxidative Pathway: The Involvement of AMPK/Akt/GSK3β
por: Fan, Xiaoye, et al.
Publicado: (2018)

Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
por: Cucci, Marie Angèle, et al.
Publicado: (2023)

The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer
por: Tian, Lei, et al.
Publicado: (2022)

Drug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG-PAMAM nanoparticles
por: Zou, Liang, et al.
Publicado: (2017)

Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin
por: Xu, Yingqi, et al.
Publicado: (2017)

Daphnetin Attenuated Cisplatin-Induced Acute Nephrotoxicity With Enhancing Antitumor Activity of Cisplatin by Upregulating SIRT1/SIRT6-Nrf2 Pathway
por: Fan, Xiaoye, et al.
Publicado: (2020)

FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/NRF2 signaling pathway
por: Zhou, Yunjiang, et al.
Publicado: (2023)

Isoorientin Attenuates Cisplatin-Induced Nephrotoxicity Through the Inhibition of Oxidative Stress and Apoptosis via Activating the SIRT1/SIRT6/Nrf-2 Pathway
por: Fan, Xiaoye, et al.
Publicado: (2020)

Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients
por: Reszka, Edyta, et al.
Publicado: (2014)

How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy
por: Tang, Ya-Chu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dntiauot1jheocec5q0q4gm13d